arrow downskip to content skip to navigation
Datwyler Logo
  • Healthcare
    • Applications
      • Vials
      • Prefilled Syringes
      • Cartridges
      • Blood collection
      • Single-use Syringes
    • Service Offering
      • StarterPack™
      • Packaging & Sterilization
      • Regulatory Support
    • Manufacturing levels
      • FirstLine®
  • Mobility
    • Applications
      • Advanced Technologies
      • Battery Systems
      • Brake Systems
      • Electrified Powertrain
      • Emission Reduction Systems
      • Fuel Cells
      • Vehicle Interior
    • Solution Design
      • Simulation
    • Material Expertise
      • Materials for Electrification
      • Technology & Innovation Labs
    • Operational Excellence
      • O-Rings
      • Liquid Silicone Rubber
      • Global Network
  • Connectors
  • General Industry
    • Services
      • Feasibility Check
    • Markets
      • Energy Generation
      • Drinking Water and Heating
    • Products
    • Offering
  • Food & Beverage
    • Products & Services
      • Form in Place Gaskets
      • Deep Drawing
    • Industrialization Partner
  • Company
    • About us
      • Values
      • History
    • Strategy
      • Sustainability
      • Agility
      • Digitalization
      • Profitable growth
    • Core competencies
      • Solution design
      • Material expertise
      • Operational excellence
    • Innovation
      • Advanced technologies
      • Electro Active Polymers (EAP)
      • SoftPulse™
    • Governance
      • Board of Directors
      • Executive Management
      • Compliance
      • Shareholder Structure
    • Careers
      • Apprenticeship
      • Pension Fund
  • Contact
  • Media
  • Supplier
  • Investors
  • Careers
  • Sitemap

Why Pharma Should be
Focusing on ESG

Report | May 2, 2022
The concept of sustainability has evolved over time and is no longer solely focused on harmful emissions into the atmosphere. Today, it is an umbrella term for environmental, social, and governance (ESG) issues.

Read Datwyler's white paper on "Why Pharma Should be Focusing on ESG" to learn more about how the pharma industry is taking charge to improve these critical issues.

ESG Report 2022 - ESG in Pharma

Why Pharma Should be Focusing on ESG

ESG Report 2022

Book icon PDF, 1.44 MB

Focus

  • Healthcare Healthcare

Strategy

  • Sustainability Sustainability
Home Media News ESG Report 2022 - ESG in Pharma
Dätwyler Logo
  • Healthcare
  • Mobility
  • Connectors
  • General Industry
  • Food & Beverage
  • Company
  • Media
  • Supplier
  • Careers
  • Investors
  • Contact
  • Search
  • Sitemap
  • Privacy Policy
  • Imprint

© 2023 Dätwyler Holding Inc.

Cookie settings

To enjoy the entire content and full feature set of this website and allow us to anonymously track data for statistical and analytical purposes it is necessary to set cookies. It's your choice to allow this. Learn more in our Privacy policy.

Language settings